Contineum Therapeutics (CTNM) Stock Chart & Stock Price History $4.41 -0.11 (-2.43%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$4.42 +0.01 (+0.34%) As of 04/25/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Contineum Therapeutics Stock Price Performance 5 Day Performance-10.91%1 Month Performance-39.42%3 Month Performance-60.55%6 Month Performance-73.58%Year-To-Date Performance-69.90%1 Year Performance-71.95% Receive CTNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CTNM Stock Chart for Saturday, April, 26, 2025 CTNM Chart by TradingView Contineum Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2025$4.52$4.41-2.43%$4.61$4.3648,213 shs$114.10 million04/24/2025$4.74$4.52-4.64%$4.80$4.4758,735 shs$116.94 million04/23/2025$4.90$4.74-3.27%$5.25$4.7252,210 shs$122.63 million04/22/2025$4.95$4.90-1.01%$5.26$4.8563,010 shs$126.77 million04/21/2025$4.62$4.95+7.14%$5.00$4.34153,589 shs$128.07 million04/18/2025$4.62$4.62$4.88$4.30139,450 shs$119.53 million04/17/2025$4.38$4.62+5.48%$4.88$4.30139,450 shs$119.53 million04/16/2025$4.11$4.38+6.57%$4.57$3.85174,692 shs$113.32 million04/15/2025$3.99$4.11+3.01%$4.38$3.9988,647 shs$106.33 million04/14/2025$4.01$3.99-0.50%$4.21$3.91104,641 shs$103.23 million Get the Latest News and Ratings for CTNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/11/2025$4.13$4.01-2.91%$4.24$3.9166,573 shs$103.75 million04/10/2025$4.62$4.13-10.61%$4.57$4.0485,571 shs$106.85 million04/09/2025$4.79$4.62-3.55%$4.79$4.15168,594 shs$119.53 million04/09/2025$4.79$4.62-3.55%$4.79$4.15168,594 shs$119.53 million04/08/2025$5.37$4.79-10.80%$5.75$4.7652,027 shs$123.93 million04/08/2025$5.37$4.79-10.80%$5.75$4.7652,027 shs$123.93 million04/07/2025$5.80$5.37-7.41%$5.90$5.25105,292 shs$138.93 million04/04/2025$6.13$5.80-5.38%$6.15$5.5969,511 shs$150.06 million04/03/2025$6.78$6.13-9.59%$6.95$6.1187,617 shs$158.60 million04/02/2025$6.46$6.78+4.95%$6.97$6.3430,956 shs$175.41 million04/01/2025$6.98$6.46-7.45%$6.96$6.3824,668 shs$167.13 million03/31/2025$7.07$6.98-1.27%$7.20$6.8277,531 shs$180.59 million03/28/2025$7.45$7.07-5.10%$7.58$7.0148,922 shs$182.92 million03/27/2025$7.28$7.45+2.34%$7.65$7.1330,626 shs$192.75 million03/26/2025$7.91$7.28-7.96%$7.75$7.1336,197 shs$188.35 million03/25/2025$7.76$7.91+1.93%$8.00$7.5440,431 shs$204.65 million Related Companies PGEN Stock Chart MNMD Stock Chart STOK Stock Chart UPB Stock Chart PRTC Stock Chart SANA Stock Chart SION Stock Chart RVNC Stock Chart ABVX Stock Chart ZVRA Stock Chart Receive CTNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTNM) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTNM Stock Free CTNM Stock Alerts